SlideShare a Scribd company logo
1 of 18
LAPORAN KASUS
Gravida dengan Thalasemia
Ny. I/ 24 th/ Menikah 1x, I :5 th/ P1002Ab000/ AT : 4 th/ Kontrasepsi : -/ HPHT :
06 Juli 2022 ~ 32-34 minggu
Alamat : Jln Kawi Metro 75B, Sukun Kepanjen. Malang
Pasien konsulan TS IPD dengan G2P2Ab0 gr 30 – 32 mgg + Thalasemia beta minor
Januari 2019
Pasien mengeluh lemas disertai keluar cairan dari jalan lahir saat kehamilan pertama  Ke RS
Kanjuruhan  dilakukan pemeriksaan, didapatkan Hb 6,4, dari pemeriksaan TS IPD didapatkan
hasil thalassemia beta minor  Disarankan SCTP
25 Januari 2023
Pasien tiba di Poli penyakit dalam RSSA  dilakukan pemeriksaan, karena kondisi hamil  Konsul
TS OBG
25 Januari 2023
Pasien tiba di Poli hamil RSSA
- Riwayat Thalassemia Beta minor 2019, rutin berobat sejak 1 tahun terakhir dan riw transfusi di RSUD
Kanjuruhan
- Riwayat terapi thalasemia dengan exjade 1x1000 mg
selama hamil terapi deferasirox 1x1000 mg + Vit B complex + Asam folat
- Riwayat keluarga dengan thalassemia disangkal
- Riwayat HT, DM, penyakit jantung disangkal
- Riwayat operasi sebelumnya SC th 2019 ai KPD
- Riwayat vaksin COVID-19 1x, Sinovac
RIWAYAT OBSTETRI
1. Preterm/ 1400 gr/ SCTP ai KPD + Thalassemia beta (Hb 4)/ SpOG di RSUD Kanjuruhan/ P/
4 th/ H
2. Preterm/ 1600 gr/ SCTP ai KPD + Thalassemia beta (Hb 4)/ SpOG di RSUD Kanjuruhan/ P/
4 th/ H
3. Hamil ini
KB : -
HPHT : 06 July 2022 ~ 32-34 minggu
ANC
RSSA : 2x (terakhir kontrol 13/02/2023)
Bidan : 4x
Obyektif
KU : Cukup GC9 456
TD : 113/70 mmHg
N : 107 x/menit
RR : 20 x/menit
SpO2 : 97% on room air
BB sebelum hamil : 50 kg
BB : 55 kg
TB : 160 cm,
BMI : 22 kg/m2
K/L : anemia +|+, icteric -|-
Thorax : C/ S1 S2 single, murmur (-)
P/ Rh ≡ | ≡ , Wh ≡ | ≡
Abdomen :TFU 23 cm, Letak bujur U, TBJ : 1716 gr.
HIS (-), DJJ 142x/m, Scar pfanensteil (+)
GE : Flux (-), fluor (-)
06 July 2022 ~ 32-34 minggu
TBJ : 1420
gr
EFW : 1481 gr
DJJ : 143 x/mnt
AFI : 5,01 cm
Placenta implantasi di fundus
Maturasi gr II
Laboratorium :
DL : 4,6/13.920/17/114.000
FH : 9,3/ 30,3
OT/PT : 38/39
Alb : 3,73
GDS : 80
Ur/Cr : 24,3/0,7
SE : 125/3,89/119
HDT (26/4/19) :
Eritrosit : Hipokrom Anisopoikilositosis, Target cell (+),Makro
Ovalosit(+), Tear drop cell (+), Eliptosit (+), Normoblas 6/100
tLeukosit : kesan jumlah normal, atypical limfosit (+)
Trombosit : kesan jumlah normal, giant trombosit (+)
Coomb`s test : +2Hb-Assay (Capillary Electrophoresis)
- Hb F 28,6%
- Hb A 5,8%- Hb A2 6,0%
- Kesan : Thalassemia Beta dan HbE disease
Assesment
G2P1002Ab000 gr 32-34 mgg T/H
+ Thalasemia Beta minor
+ BSC 1x
Planning
PDx :
PTx :
- SF 2x1 tab
TS IPD
Assesment
Thalasemia Beta minor
+ G2P1002Ab000 gr 32-34 mgg T/H
Planning
PDx :
PTx :
- Deferasirox 1x1000 mg
- Vit B comp 3x1
Pembahasan
Cunningham, F. Gary, et al. Williams Obstetrics. [New York], McGraw Hill Medical, 2022.
Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean Journal of Hematology and Infectious Diseases, vol.
11, no. 1, 26 Feb. 2019, p. e2019019, https://doi.org/10.4084/mjhid.2019.019.
Green-Top Guideline No. 66: Management of Beta Thalassaemia in Pregnancy.” The Obstetrician & Gynaecologist,
vol. 16, no. 2, Apr. 2014, pp. 148–148, https://doi.org/10.1111/tog.12100. Accessed 1 Dec. 2019.
PEMBAHASAN
Assesment
G2P1002Ab000 gr 32-34 mgg T/H
+ Thalasemia Beta minor
+ BSC 1x
 Cunningham, F. Gary, et al. Williams Obstetrics. [New York], McGraw Hill Medical, 2022.
PEMBAHASAN
Laboratorium :
DL : 4,6/13.920/17/114.000
HDT (26/4/19) :
Eritrosit : Hipokrom Anisopoikilositosis, Target cell
(+),Makro Ovalosit(+), Tear drop cell (+), Eliptosit (+),
Normoblas 6/100
tLeukosit : kesan jumlah normal, atypical limfosit (+)
Trombosit : kesan jumlah normal, giant trombosit (+)
Coomb`s test : +2Hb-Assay (Capillary Electrophoresis)
Hb F 28,6%
Hb A 5,8%- Hb A2 6,0%
Kesan : Thalassemia Beta dan HbE disease
Cunningham, F. Gary, et al. Williams Obstetrics. [New York],
McGraw Hill Medical, 2022
---. “Beta-Thalassemia Minor during Pregnancy.” Obstetrics & Gynecology,
vol. 103, no. 6, June 2004, pp. 1273–1277,
Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean
Journal of Hematology and Infectious Diseases, vol. 11, no. 1, 26 Feb. 2019, p. e2019019,
https://doi.org/10.4084/mjhid.2019.019.
Sheiner, Eyal, et al. “Beta-Thalassemia Minor during Pregnancy.” Obstetrics & Gynecology, vol. 103, no. 6, June 2004, pp.
1273–1277,
06 July 2022 ~ 32-34 minggu
TBJ : 1420
gr
EFW : 1481 gr
DJJ : 143 x/mnt
AFI : 5,01 cm
Placenta implantasi di fundus
Maturasi gr II
Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean
Journal of Hematology and Infectious Diseases, vol. 11, no. 1, 26 Feb. 2019, p. e2019019,
https://doi.org/10.4084/mjhid.2019.019.
PEMBAHASAN
Planning
PDx :
PTx :
- Deferasirox 1x1000 mg
- Vit B comp 3x1
- Asam folat 2x1
Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean Journal of Hematology and Infectious Diseases, vol.
11, no. 1, 26 Feb. 2019, p. e2019019, https://doi.org/10.4084/mjhid.2019.019.
Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean Journal of Hematology and Infectious Diseases, vol.
11, no. 1, 26 Feb. 2019, p. e2019019, https://doi.org/10.4084/mjhid.2019.019.
Terima Kasih

More Related Content

Similar to LAPKAS gravida thalasemia.pptx

High risk pregnancy cases
High risk pregnancy casesHigh risk pregnancy cases
High risk pregnancy casesnamkha dorji
 
Association of Lipid Profile and Uric Acid with Pre-Eclampsia of Third Trimes...
Association of Lipid Profile and Uric Acid with Pre-Eclampsia of Third Trimes...Association of Lipid Profile and Uric Acid with Pre-Eclampsia of Third Trimes...
Association of Lipid Profile and Uric Acid with Pre-Eclampsia of Third Trimes...Pulak Das
 
familial adenomatous polyposis
familial adenomatous polyposisfamilial adenomatous polyposis
familial adenomatous polyposisved sah
 
OHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI CyclesOHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI CyclesSandro Esteves
 
irwan idris.pptx
irwan idris.pptxirwan idris.pptx
irwan idris.pptxhaidir0693
 
Approching children with poor weight gain.pptx
Approching children with poor weight gain.pptxApproching children with poor weight gain.pptx
Approching children with poor weight gain.pptxFadhlyShariman
 
COPD and Key Indicators For Considering Diagnosis
COPD and Key Indicators For Considering DiagnosisCOPD and Key Indicators For Considering Diagnosis
COPD and Key Indicators For Considering DiagnosisSoroy Lardo
 
By Ny Ayu Febiola.pptx
By Ny Ayu Febiola.pptxBy Ny Ayu Febiola.pptx
By Ny Ayu Febiola.pptxNicholas Redly
 
Gestational trophoblastic disease-Hamisi Mkindi
Gestational trophoblastic disease-Hamisi Mkindi Gestational trophoblastic disease-Hamisi Mkindi
Gestational trophoblastic disease-Hamisi Mkindi Mkindi Mkindi
 
wk highorder px - Copy.pptx
wk highorder px - Copy.pptxwk highorder px - Copy.pptx
wk highorder px - Copy.pptxwendekassahun
 
PERINATAL MORTALITY.pptx of our ppt or.pdfallowed
PERINATAL MORTALITY.pptx of our ppt or.pdfallowedPERINATAL MORTALITY.pptx of our ppt or.pdfallowed
PERINATAL MORTALITY.pptx of our ppt or.pdfallowedManzarKing
 
OB_Hypertensive-Disorders_DuldulaoFernandez.pdf
OB_Hypertensive-Disorders_DuldulaoFernandez.pdfOB_Hypertensive-Disorders_DuldulaoFernandez.pdf
OB_Hypertensive-Disorders_DuldulaoFernandez.pdfRaquelReyes87
 

Similar to LAPKAS gravida thalasemia.pptx (20)

High risk pregnancy cases
High risk pregnancy casesHigh risk pregnancy cases
High risk pregnancy cases
 
D10.pptx
D10.pptxD10.pptx
D10.pptx
 
Association of Lipid Profile and Uric Acid with Pre-Eclampsia of Third Trimes...
Association of Lipid Profile and Uric Acid with Pre-Eclampsia of Third Trimes...Association of Lipid Profile and Uric Acid with Pre-Eclampsia of Third Trimes...
Association of Lipid Profile and Uric Acid with Pre-Eclampsia of Third Trimes...
 
familial adenomatous polyposis
familial adenomatous polyposisfamilial adenomatous polyposis
familial adenomatous polyposis
 
cole embarazo.pptx
cole embarazo.pptxcole embarazo.pptx
cole embarazo.pptx
 
Diabetes in Pregnancy Gestational Diabetes - Idea Clinics | Institute of Diab...
Diabetes in Pregnancy Gestational Diabetes - Idea Clinics | Institute of Diab...Diabetes in Pregnancy Gestational Diabetes - Idea Clinics | Institute of Diab...
Diabetes in Pregnancy Gestational Diabetes - Idea Clinics | Institute of Diab...
 
suction and curettage
suction and curettagesuction and curettage
suction and curettage
 
P 411
P 411P 411
P 411
 
OHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI CyclesOHSS Management in OI/IUI Cycles
OHSS Management in OI/IUI Cycles
 
irwan idris.pptx
irwan idris.pptxirwan idris.pptx
irwan idris.pptx
 
Approching children with poor weight gain.pptx
Approching children with poor weight gain.pptxApproching children with poor weight gain.pptx
Approching children with poor weight gain.pptx
 
COPD and Key Indicators For Considering Diagnosis
COPD and Key Indicators For Considering DiagnosisCOPD and Key Indicators For Considering Diagnosis
COPD and Key Indicators For Considering Diagnosis
 
By Ny Ayu Febiola.pptx
By Ny Ayu Febiola.pptxBy Ny Ayu Febiola.pptx
By Ny Ayu Febiola.pptx
 
Gestational trophoblastic disease-Hamisi Mkindi
Gestational trophoblastic disease-Hamisi Mkindi Gestational trophoblastic disease-Hamisi Mkindi
Gestational trophoblastic disease-Hamisi Mkindi
 
wk highorder px - Copy.pptx
wk highorder px - Copy.pptxwk highorder px - Copy.pptx
wk highorder px - Copy.pptx
 
PERINATAL MORTALITY.pptx of our ppt or.pdfallowed
PERINATAL MORTALITY.pptx of our ppt or.pdfallowedPERINATAL MORTALITY.pptx of our ppt or.pdfallowed
PERINATAL MORTALITY.pptx of our ppt or.pdfallowed
 
Neonatal jaundice
Neonatal jaundice Neonatal jaundice
Neonatal jaundice
 
Preterm labor by audace
Preterm labor by audacePreterm labor by audace
Preterm labor by audace
 
OB_Hypertensive-Disorders_DuldulaoFernandez.pdf
OB_Hypertensive-Disorders_DuldulaoFernandez.pdfOB_Hypertensive-Disorders_DuldulaoFernandez.pdf
OB_Hypertensive-Disorders_DuldulaoFernandez.pdf
 
Subfertility
SubfertilitySubfertility
Subfertility
 

Recently uploaded

End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feeldranji1
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartMedicoseAcademics
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxDr. Dheeraj Kumar
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Catherine Liao
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionGolden Helix
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadNephroTube - Dr.Gawad
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...KavyasriPuttamreddy
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingMedicoseAcademics
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAkashGanganePatil1
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationMedicoseAcademics
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptxdr shahida
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCatherine Liao
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryDr Simran Deepak Vangani
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)Monika Kanwar
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentabdeli bhadarva
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerSherrylee83
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumassuser144901
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSuresh Kumar K
 
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdfรายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdfVorawut Wongumpornpinit
 

Recently uploaded (20)

End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptx
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptxSURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
SURGICAL ANATOMY OF ORAL IMPLANTOLOGY.pptx
 
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdfรายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
 

LAPKAS gravida thalasemia.pptx

  • 2. Ny. I/ 24 th/ Menikah 1x, I :5 th/ P1002Ab000/ AT : 4 th/ Kontrasepsi : -/ HPHT : 06 Juli 2022 ~ 32-34 minggu Alamat : Jln Kawi Metro 75B, Sukun Kepanjen. Malang Pasien konsulan TS IPD dengan G2P2Ab0 gr 30 – 32 mgg + Thalasemia beta minor Januari 2019 Pasien mengeluh lemas disertai keluar cairan dari jalan lahir saat kehamilan pertama  Ke RS Kanjuruhan  dilakukan pemeriksaan, didapatkan Hb 6,4, dari pemeriksaan TS IPD didapatkan hasil thalassemia beta minor  Disarankan SCTP 25 Januari 2023 Pasien tiba di Poli penyakit dalam RSSA  dilakukan pemeriksaan, karena kondisi hamil  Konsul TS OBG 25 Januari 2023 Pasien tiba di Poli hamil RSSA
  • 3. - Riwayat Thalassemia Beta minor 2019, rutin berobat sejak 1 tahun terakhir dan riw transfusi di RSUD Kanjuruhan - Riwayat terapi thalasemia dengan exjade 1x1000 mg selama hamil terapi deferasirox 1x1000 mg + Vit B complex + Asam folat - Riwayat keluarga dengan thalassemia disangkal - Riwayat HT, DM, penyakit jantung disangkal - Riwayat operasi sebelumnya SC th 2019 ai KPD - Riwayat vaksin COVID-19 1x, Sinovac
  • 4. RIWAYAT OBSTETRI 1. Preterm/ 1400 gr/ SCTP ai KPD + Thalassemia beta (Hb 4)/ SpOG di RSUD Kanjuruhan/ P/ 4 th/ H 2. Preterm/ 1600 gr/ SCTP ai KPD + Thalassemia beta (Hb 4)/ SpOG di RSUD Kanjuruhan/ P/ 4 th/ H 3. Hamil ini KB : - HPHT : 06 July 2022 ~ 32-34 minggu ANC RSSA : 2x (terakhir kontrol 13/02/2023) Bidan : 4x
  • 5. Obyektif KU : Cukup GC9 456 TD : 113/70 mmHg N : 107 x/menit RR : 20 x/menit SpO2 : 97% on room air BB sebelum hamil : 50 kg BB : 55 kg TB : 160 cm, BMI : 22 kg/m2 K/L : anemia +|+, icteric -|- Thorax : C/ S1 S2 single, murmur (-) P/ Rh ≡ | ≡ , Wh ≡ | ≡ Abdomen :TFU 23 cm, Letak bujur U, TBJ : 1716 gr. HIS (-), DJJ 142x/m, Scar pfanensteil (+) GE : Flux (-), fluor (-)
  • 6. 06 July 2022 ~ 32-34 minggu TBJ : 1420 gr EFW : 1481 gr DJJ : 143 x/mnt AFI : 5,01 cm Placenta implantasi di fundus Maturasi gr II Laboratorium : DL : 4,6/13.920/17/114.000 FH : 9,3/ 30,3 OT/PT : 38/39 Alb : 3,73 GDS : 80 Ur/Cr : 24,3/0,7 SE : 125/3,89/119 HDT (26/4/19) : Eritrosit : Hipokrom Anisopoikilositosis, Target cell (+),Makro Ovalosit(+), Tear drop cell (+), Eliptosit (+), Normoblas 6/100 tLeukosit : kesan jumlah normal, atypical limfosit (+) Trombosit : kesan jumlah normal, giant trombosit (+) Coomb`s test : +2Hb-Assay (Capillary Electrophoresis) - Hb F 28,6% - Hb A 5,8%- Hb A2 6,0% - Kesan : Thalassemia Beta dan HbE disease
  • 7. Assesment G2P1002Ab000 gr 32-34 mgg T/H + Thalasemia Beta minor + BSC 1x Planning PDx : PTx : - SF 2x1 tab
  • 8. TS IPD Assesment Thalasemia Beta minor + G2P1002Ab000 gr 32-34 mgg T/H Planning PDx : PTx : - Deferasirox 1x1000 mg - Vit B comp 3x1
  • 10. Cunningham, F. Gary, et al. Williams Obstetrics. [New York], McGraw Hill Medical, 2022. Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean Journal of Hematology and Infectious Diseases, vol. 11, no. 1, 26 Feb. 2019, p. e2019019, https://doi.org/10.4084/mjhid.2019.019. Green-Top Guideline No. 66: Management of Beta Thalassaemia in Pregnancy.” The Obstetrician & Gynaecologist, vol. 16, no. 2, Apr. 2014, pp. 148–148, https://doi.org/10.1111/tog.12100. Accessed 1 Dec. 2019.
  • 11. PEMBAHASAN Assesment G2P1002Ab000 gr 32-34 mgg T/H + Thalasemia Beta minor + BSC 1x  Cunningham, F. Gary, et al. Williams Obstetrics. [New York], McGraw Hill Medical, 2022.
  • 12. PEMBAHASAN Laboratorium : DL : 4,6/13.920/17/114.000 HDT (26/4/19) : Eritrosit : Hipokrom Anisopoikilositosis, Target cell (+),Makro Ovalosit(+), Tear drop cell (+), Eliptosit (+), Normoblas 6/100 tLeukosit : kesan jumlah normal, atypical limfosit (+) Trombosit : kesan jumlah normal, giant trombosit (+) Coomb`s test : +2Hb-Assay (Capillary Electrophoresis) Hb F 28,6% Hb A 5,8%- Hb A2 6,0% Kesan : Thalassemia Beta dan HbE disease Cunningham, F. Gary, et al. Williams Obstetrics. [New York], McGraw Hill Medical, 2022 ---. “Beta-Thalassemia Minor during Pregnancy.” Obstetrics & Gynecology, vol. 103, no. 6, June 2004, pp. 1273–1277,
  • 13. Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean Journal of Hematology and Infectious Diseases, vol. 11, no. 1, 26 Feb. 2019, p. e2019019, https://doi.org/10.4084/mjhid.2019.019. Sheiner, Eyal, et al. “Beta-Thalassemia Minor during Pregnancy.” Obstetrics & Gynecology, vol. 103, no. 6, June 2004, pp. 1273–1277, 06 July 2022 ~ 32-34 minggu TBJ : 1420 gr EFW : 1481 gr DJJ : 143 x/mnt AFI : 5,01 cm Placenta implantasi di fundus Maturasi gr II
  • 14. Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean Journal of Hematology and Infectious Diseases, vol. 11, no. 1, 26 Feb. 2019, p. e2019019, https://doi.org/10.4084/mjhid.2019.019. PEMBAHASAN Planning PDx : PTx : - Deferasirox 1x1000 mg - Vit B comp 3x1 - Asam folat 2x1
  • 15. Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean Journal of Hematology and Infectious Diseases, vol. 11, no. 1, 26 Feb. 2019, p. e2019019, https://doi.org/10.4084/mjhid.2019.019.
  • 16. Origa, Raffaella, and Federica Comitini. “PREGNANCY in THALASSEMIA.” Mediterranean Journal of Hematology and Infectious Diseases, vol. 11, no. 1, 26 Feb. 2019, p. e2019019, https://doi.org/10.4084/mjhid.2019.019.
  • 17.

Editor's Notes

  1. Thalassemia adalah sekelompok kelainan darah herediter yang ditandai dengan penurunan atau penekanan produksi sintesis rantai globin dari hemoglobin. diklasifikasikan menurut rantai globin yang rusak yang menghasilkan berbagai fenotipe mulai dari anemia berat hingga individu tanpa gejala klinis. Hemoglobinopathies adalah salah satu kelainan bawaan yang paling umum. Lebih dari 70.000 bayi lahir dengan thalassemia di seluruh dunia setiap tahun2 dan ada 100 juta orang yang merupakan pembawa thalassemia asimtomatik. Cacat dasar pada sindrom talasemia adalah berkurangnya sintesis rantai globin dengan sel darah merah yang dihasilkan memiliki kandungan hemoglobin yang tidak memadai. Ratusan mutasi memengaruhi gen yang mengontrol produksi hemoglobin (Benz, 2018). Beberapa di antaranya merusak sintesis satu atau lebih peptida globin normal dan dapat mengakibatkan sindrom klinis yang ditandai dengan berbagai derajat eritropoiesis, hemolisis, dan anemia yang tidak efektif. Thalassemia diklasifikasikan menurut globin yang kurang. Dua bentuk utama melibatkan gangguan produksi atau ketidakstabilan α-globin menyebabkan αthalassemia atau β-globin menyebabkan β-thalassemia. Secara klinis, ini dapat dibagi menjadi ketergantungan transfusi dan ketergantungan nontransfusi (Taher, 2018).
  2. The β-thalassemia berasal dari gangguan produksi β-globin atau ketidakstabilan α-globin. Gen yang menyandikan kontrol sintesis β-globin berada di kluster gen δγβ- pada kromosom 11/ Lebih dari 150 titik mutasi pada gen βglobin telah dijelaskan (Weatherall, 2010). Pada thalassemia β, produksi globin β menurun, dan kelebihan globin α mengendap untuk merusak membran sel. Bentuk lain dari thalassemia β berasal dari ketidakstabilan globin α (Kihm, 2002). Sifat heterozigot adalah β-thalassemia minor, dan yang paling sering dijumpai adalah peningkatan hemoglobin A2tingkat. Hemoglobin ini terdiri dari dua α- dan dua δ-globin, dan konsentrasi biasanya lebih dari 3,5 persen.
  3. Thalassemia minor menyebabkan derajat penyakit yang bervariasi tetapi, tergantung pada tingkat rantainya produksi, biasanya muncul sebagai anemia asimtomatik derajat ringan (hemoglobin 1-2 g/dL lebih rendah dari orang normal dengan usia dan jenis kelamin yang sama). Tidak ada terapi khusus untuk thalassemia minor selama kehamilan, tetapi jika anemia menjadi lebih parah, terkadang diperlukan transfusi. Sedikit yang dilaporkan mengenai hasil perinatal pasien dengan -thalassemia minor. Beberapa studi termasuk sejumlah kecil pasien menyarankan hasil yang menguntungkan.2,7,10 Kesuburan secara umum diantara pasien tersebut tidak mengalami gangguan, dan tidak mengalami menstruasi kelainan yang ada.2 Demikian juga, kejadian bayi prematur dan bayi berat lahir rendah ditemukan sebanding dengan populasi umum.Namun, beberapa hasil buruk yang dilaporkan disebabkan oleh hiperkoagulabilitas,11 dan kebutuhan akan lebih banyak data, terutama untuk kelompok heterogen pasien thalassemia minor Hemoglobin F—terdiri dari dua α- dan dua γ-globin juga biasanya mengalami peningkatan konsentrasi yang melebihi 2 persen. Beberapa pasien dengan heterozigot β-thalassemia minor tidak mengalami anemia, dan yang lainnya mengalami anemia ringan sampai sedang yang ditandai dengan hipokromia dan mikrositosis